Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Requip

Active ingredient: Ropinirole

Neutral reference profile for an independent medicine-access consultancy enquiry about Requip (Ropinirole). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Requip used for?

Requip (ropinirole) is a prescription medicine for the treatment of Parkinson’s disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

Requip (ropinirole) is available as tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, and 5 mg).

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Requip identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordRequip
Active ingredientRopinirole
Dosage formfilm-coated tablets, tablets
Recorded options9
Directory areaNeurology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 0.25 mg · 21 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  2. 0.5 mg · 21 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  3. 1.0 mg · 84 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  4. 2 mg · 28 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  5. 2 mg · 84 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  6. 2.0 mg · 84 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  7. 4 mg · 84 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  8. 5.0 mg · 84 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG
  9. 8 mg · 84 tablets Catalogue organisation: GlaxoSmithKline GmbH & Co. KG

SERVICE BOUNDARY

Information checking and independent enquiry support for Requip.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Requip

01What is Requip?

This directory record associates the brand name Requip with the active ingredient Ropinirole. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Requip strengths and packs are recorded?

The catalogue currently shows: 0.25 mg · 21 tablets; 0.5 mg · 21 tablets; 1.0 mg · 84 tablets; 2 mg · 28 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Requip?

Catalogue records currently name: GlaxoSmithKline GmbH & Co. KG. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Requip?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Requip, payment request, stock guarantee or binding offer.

06Can I buy Requip from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.